Audio By Carbonatix
Lead vaccine candidates developed by Oxford University and Moderna against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo, could enter Phase 1 trials as early as July.
They say that field trials possible within several months, the head of the Coalition for Epidemic Preparedness Innovations, Richard Hatchett, said on Tuesday.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Tags:
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Police receive DNA report in murdered Immigration officer’s case, await full autopsy report
32 minutes -
Labadi Beach Hotel pays SSNIT GH¢17.8m dividend, bigger payout expected this year – Afreh Biney
42 minutes -
We will not sell them – SSNIT boss ends speculation over Labadi Beach Hotel and La Palm
59 minutes -
World Bank approves $300m support package to help Ghana end double-track system by 2027
1 hour -
Messi equals World Cup goals record with hat-trick in Argentina win
1 hour -
Retirement age reform requires national consensus, not a SSNIT decision – Afreh Biney
2 hours -
Extending retirement age could delay opportunities for youth by up to 7 years – SSNIT boss
2 hours -
Jamaica in talks to accept third-country migrants deported from US
2 hours -
G7 leaders call for strong, coordinated response to Ebola outbreak
2 hours -
Ebola Bundibugyo vaccine candidates could enter Phase 1 trials as early as July
2 hours